这篇文章不错，转发给_老虎社区_美港股上老虎 - 老虎社区

复利是世界上第八大奇迹

这篇文章不错，转发给大家看看

@今日新闻：百时美施贵宝公司将以74亿美元的医药交易收购Celgene

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":396426921,"tweetId":"396426921","gmtCreate":1607298709563,"gmtModify":1703846935014,"author":{"id":3533957941825240,"idStr":"3533957941825240","authorId":3533957941825240,"authorIdStr":"3533957941825240","name":"复利是世界上第八大奇迹","avatar":"https://static.tigerbbs.com/8982c92a9f0b6f713b0f1dfbf6e7e6af","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":9,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>这篇文章不错，转发给大家看看</p></body></html>","htmlText":"<html><head></head><body><p>这篇文章不错，转发给大家看看</p></body></html>","text":"这篇文章不错，转发给大家看看","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/396426921","repostId":369644,"repostType":1,"repost":{"magic":2,"id":369644,"tweetId":"369644","gmtCreate":1546518557502,"gmtModify":1704785651890,"author":{"id":34550872632897,"idStr":"34550872632897","authorId":34550872632897,"authorIdStr":"34550872632897","name":"今日新闻","avatar":"https://static.tigerbbs.com/17e95cbcbf19f0309585055e187b66cb","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1554,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"百时美施贵宝公司将以74亿美元的医药交易收购Celgene","extraTitle":"","html":"<html><head></head><body><p>（彭博社）$施贵宝(BMY)$同意收购$新基公司(CELG)$公司 以740亿美元的现金和股票交易，创建一家可与世界上最大的制药商竞争的制药巨头。</p> <p><span>施贵宝盘前下跌10%，新基盘前上涨30%</span></p> <p>根据周四的一份声明，Celgene的股东将获得一份百时美施贵宝股票和每股Celgene股票的50美元现金。</p> <p>重要见解</p> <p>该协议将把重磅炸弹抗癌药物Revlimid添加到Bristol-Myers Squibb的阵容中。两家公司表示，合并后的公司将拥有9款年销售额超过10亿美元的产品。他们认为“肿瘤学，免疫学，炎症和心血管疾病等核心疾病领域的增长潜力巨大。”</p> <p>据报道，摩根士丹利和MUFG正在提供承诺的债务融资</p> <p><span>摩根士丹利</span>还是<span>施贵宝</span>的首席财务顾问</p> <p>交易的现金部分也由手头现金提供资金</p> <p></p> <p></p></body></html>","htmlText":"<html><head></head><body><p>（彭博社）$施贵宝(BMY)$同意收购$新基公司(CELG)$公司 以740亿美元的现金和股票交易，创建一家可与世界上最大的制药商竞争的制药巨头。</p> <p><span>施贵宝盘前下跌10%，新基盘前上涨30%</span></p> <p>根据周四的一份声明，Celgene的股东将获得一份百时美施贵宝股票和每股Celgene股票的50美元现金。</p> <p>重要见解</p> <p>该协议将把重磅炸弹抗癌药物Revlimid添加到Bristol-Myers Squibb的阵容中。两家公司表示，合并后的公司将拥有9款年销售额超过10亿美元的产品。他们认为“肿瘤学，免疫学，炎症和心血管疾病等核心疾病领域的增长潜力巨大。”</p> <p>据报道，摩根士丹利和MUFG正在提供承诺的债务融资</p> <p><span>摩根士丹利</span>还是<span>施贵宝</span>的首席财务顾问</p> <p>交易的现金部分也由手头现金提供资金</p> <p></p> <p></p></body></html>","text":"（彭博社）$施贵宝(BMY)$同意收购$新基公司(CELG)$公司 以740亿美元的现金和股票交易，创建一家可与世界上最大的制药商竞争的制药巨头。 施贵宝盘前下跌10%，新基盘前上涨30% 根据周四的一份声明，Celgene的股东将获得一份百时美施贵宝股票和每股Celgene股票的50美元现金。 重要见解 该协议将把重磅炸弹抗癌药物Revlimid添加到Bristol-Myers Squibb的阵容中。两家公司表示，合并后的公司将拥有9款年销售额超过10亿美元的产品。他们认为“肿瘤学，免疫学，炎症和心血管疾病等核心疾病领域的增长潜力巨大。” 据报道，摩根士丹利和MUFG正在提供承诺的债务融资 摩根士丹利还是施贵宝的首席财务顾问 交易的现金部分也由手头现金提供资金","highlighted":1,"essential":2,"paper":2,"link":"https://laohu8.com/post/369644","repostId":0,"isVote":1,"tweetType":1,"commentLimit":10,"symbols":["BMY","CELG"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":562,"xxTargetLangEnum":"ZH_CN"},"isVote":1,"tweetType":1,"viewCount":1894,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":27,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/396426921"}